rs1386577803
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_000044.6(AR):c.2495G>A(p.Arg832Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000899 in 111,267 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R832L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000044.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AR | NM_000044.6 | c.2495G>A | p.Arg832Gln | missense_variant | 7/8 | ENST00000374690.9 | NP_000035.2 | |
AR | NM_001011645.3 | c.899G>A | p.Arg300Gln | missense_variant | 8/9 | NP_001011645.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AR | ENST00000374690.9 | c.2495G>A | p.Arg832Gln | missense_variant | 7/8 | 1 | NM_000044.6 | ENSP00000363822 | P1 | |
AR | ENST00000396044.8 | c.2174-814G>A | intron_variant | 1 | ENSP00000379359 | |||||
AR | ENST00000396043.4 | c.*843G>A | 3_prime_UTR_variant, NMD_transcript_variant | 8/9 | 1 | ENSP00000379358 | ||||
AR | ENST00000612452.5 | c.2495G>A | p.Arg832Gln | missense_variant, NMD_transcript_variant | 7/9 | 5 | ENSP00000484033 |
Frequencies
GnomAD3 genomes AF: 0.00000899 AC: 1AN: 111267Hom.: 0 Cov.: 22 AF XY: 0.0000299 AC XY: 1AN XY: 33489
GnomAD4 exome Cov.: 31
GnomAD4 genome AF: 0.00000899 AC: 1AN: 111267Hom.: 0 Cov.: 22 AF XY: 0.0000299 AC XY: 1AN XY: 33489
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Clinical Genetics and Genomics, Karolinska University Hospital | Jun 26, 2015 | - - |
Androgen resistance syndrome;C1839259:Kennedy disease Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 09, 2023 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects AR function (PMID: 2082179, 7633398, 10458483). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on AR protein function. ClinVar contains an entry for this variant (Variation ID: 458366). This variant is also known as p.Arg830Gln and p.Arg831Gln. This missense change has been observed in individuals with androgen receptor insensitivity (PMID: 2082179, 10458483, 10834333, 20150575, 26778393). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 832 of the AR protein (p.Arg832Gln). - |
Androgen resistance syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Jun 24, 2022 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with androgen insensitivity (MIM#300068), androgen insensitivity, partial, with or without breast cancer (MIM#312300), hypospadias 1, X-linked (MIM#300633), or spinal and bulbar muscular atrophy of Kennedy (MIM#313200). (I) 0109 - This gene is associated with X-linked recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to glutamine. (I) 0253 - This variant is hemizygous. (I) 0302 - Variant is present in gnomAD (v3) <0.001 for a dominant condition (0 heterozygotes, 0 homozygotes, 1 hemizygote). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated ligand binding domain of the nuclear receptor androgen receptor (NCBI conserved domains). (I) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported several times as pathogenic, and observed in hemizygous individuals with complete androgen insensitivity syndrome or aplasia of the uterus (ClinVar, DECIPHER, PMID: 30815925, PMID: 26778393, PMID: 2082179). (SP) 1001 - This variant has strong functional evidence supporting abnormal protein function. Genital fibroblasts from an affected individual were shown to abolish ligand binding ability (PMID: 2082179). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at